关注
José Aguareles
José Aguareles
Manager de Proyectos de Investigación e Innovación - Quirónsalud Madrid (T1) / Profesor asociado Universidad Alfonso X / Profesor Asociado Universidad Antonio de Nebrija / Profesor Colaborador Universidad Europea de Madrid
在 quironsalud.es 的电子邮件经过验证
标题
引用次数
引用次数
年份
VCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington’s disease
J Díaz-Alonso, J Paraíso-Luna, C Navarrete, C Del Río, I Cantarero, ...
Scientific reports 6 (1), 29789, 2016
842016
Long-term hippocampal interneuronopathy drives sex-dimorphic spatial memory impairment induced by prenatal THC exposure
A de Salas-Quiroga, D García-Rincón, D Gómez-Domínguez, M Valero, ...
Neuropsychopharmacology 45 (5), 877-886, 2020
602020
Oral administration of the cannabigerol derivative VCE-003.2 promotes subventricular zone neurogenesis and protects against mutant huntingtin-induced neurodegeneration
J Aguareles, J Paraíso-Luna, B Palomares, R Bajo-Grañeras, C Navarrete, ...
Translational neurodegeneration 8, 1-15, 2019
342019
Tenofovir disoproxil fumarate/emtricitabine and severity of coronavirus disease 2019 in people with HIV infection
J Del Amo, R Polo, S Moreno, E Martínez, A Cabello, JA Iribarren, ...
Aids 36 (15), 2171-2179, 2022
182022
Plitidepsin as a successful rescue treatment for prolonged viral SARS-CoV-2 replication in a patient with previous anti-CD20 monoclonal antibody-mediated B cell depletion and …
P Guisado-Vasco, MM Carralón-González, J Aguareles-Gorines, ...
Journal of Hematology & Oncology 15, 1-4, 2022
122022
Endocannabinoid signalling in stem cells and cerebral organoids drives differentiation to deep layer projection neurons via CB1 receptors
J Paraíso-Luna, J Aguareles, R Martín, AC Ayo-Martín, S Simón-Sánchez, ...
Development 147 (24), dev192161, 2020
122020
Contribution of altered endocannabinoid system to overactive mTORC1 signaling in focal cortical dysplasia
D García-Rincón, J Díaz-Alonso, J Paraíso-Luna, Z Ortega, J Aguareles, ...
Frontiers in Pharmacology 9, 1508, 2019
112019
Use of monoclonal antibodies in immunocompromised patients hospitalized with severe COVID-19: a retrospective multicenter cohort
J Calderón-Parra, P Guisado-Vasco, R Montejano-Sánchez, V Estrada, ...
Journal of clinical medicine 12 (3), 864, 2023
82023
VCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington’s disease. Sci Rep 6: 29789
J Díaz-Alonso, J Paraíso-Luna, C Navarrete, C Del Río, I Cantarero, ...
52016
Outcomes and clinical characteristics of the compassionate use of plitidepsin for immunocompromised adult patients with COVID-19
J Aguareles, PV Fernández, MM Carralón-González, CF Izquierdo, ...
International Journal of Infectious Diseases 135, 12-17, 2023
32023
Erratum: Flipped Inflammatory Time and the Role of Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2: Optimizing Tocilizumab Against Coronavirus Disease 2019 …
P Guisado-Vasco, J Aguareles Gorines, MM Carralón González
Erratum: Flipped Inflammatory Time and the Role of Antibodies Against Severe …, 2023
2023
Outcomes and Clinical Characteristics of the Compassionate Use of Plitidepsin for Immunocompromised Adult Patients with COVID-19 (preprint)
J Aguareles, PV Fernández, MMC González, C Forné, EMM Ballesteros, ...
2023
Correction to: Flipped Inflammatory Time and the Role of Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2: Optimizing Tocilizumab Against Coronavirus Disease 2019
J Aguareles Gorines, CG MM
The Journal of Infectious Diseases 227, 1023, 2023
2023
Flipped Inflammatory Time and the Role of Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2: Optimizing Tocilizumab Against Coronavirus Disease 2019
P Guisado-Vasco, J Aguareles Gorines, MM Carralón González, ...
The Journal of Infectious Diseases 226 (1), 1-5, 2022
2022
Desarrollo preclínico del VCE-003.2: un nuevo derivado cannabinoide con potencial neuroprotector y neurogénico
J Aguareles Gorines
Universidad Complutense de Madrid, 2021
2021
Oral administration of the cannabigerol derivative VCE-003.2 promotes subventricular zone neurogenesis and protects against mutant huntingtin-induced neurodegeneration
J Aguareles Gorines, J Paraíso Luna, B Palomares, R Bajo Grañeras, ...
2019
系统目前无法执行此操作,请稍后再试。
文章 1–16